Hyperbilirubinaemia in patients treated with recombinant human interleukin-2 (rIL-2)
Punt
C J
CJ
Henzen-Logmans
S C
SC
Bolhuis
R L
RL
Stoter
G
G
D000368:Aged; D005260:Female; D006801:Humans; D006932:Hyperbilirubinemia / Q000139:chemically induced*; D007376:Interleukin-2 / Q000009:adverse effects*; D011994:Recombinant Proteins / Q000009:adverse effects
D007376:Interleukin-2; D011994:Recombinant Proteins